Here's Why Humana (HUM) is a Strong Momentum Stock

Humana (HUM) is highlighted by Zacks as a strong momentum stock, despite its #3 (Hold) rank, due to favorable B Momentum and VGM Style Scores. The healthcare provider's shares have surged 29.9% over the past four weeks, supported by 11 analyst upgrades to its fiscal 2025 earnings estimate, which has increased the consensus to $16.99 per share, coupled with a 9.6% average earnings surprise. This combination of strong price action and positive earnings revisions positions HUM as a notable candidate for investor consideration.

Analysis

Humana Inc. (HUM) is exhibiting strong momentum indicators that are currently juxtaposed with a neutral analyst rating. The stock has appreciated 29.9% over the past four weeks, a significant move underpinned by positive revisions to its forward-looking earnings outlook. Specifically for fiscal 2025, eleven analysts have revised their earnings estimates upward within the last 60 days, elevating the Zacks Consensus Estimate by $0.62 to $16.99 per share. This forward-looking optimism is supported by a strong track record of outperformance, with the company boasting an average earnings surprise of 9.6%. While Zacks assigns HUM a neutral #3 (Hold) rank, its favorable 'B' ratings for both Momentum and its composite VGM (Value, Growth, Momentum) score suggest that its technical and fundamental characteristics warrant attention despite the absence of a formal 'Buy' recommendation from the ranking system.

Key Decisions for Investors

• Given the stock's significant 29.9% price increase in the past month, momentum-focused investors might find HUM attractive, but should be cautious about entry points after such a rapid appreciation.
• Investors should weigh the neutral Zacks #3 'Hold' rank against the strong underlying signals, particularly the 11 upward earnings revisions for FY2025, which suggest fundamental strength may be improving beyond the current rating.
• The key catalyst to monitor is the continuation of positive earnings estimate revisions, as this trend serves as the primary fundamental justification for the stock's recent price momentum.